LNSR
LENSAR IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$68.10M
P/E Ratio
—
EPS
$-2.87
Beta
0.98
52W High
$14.31
52W Low
$5.35
50-Day MA
$10.32
200-Day MA
$11.62
Dividend Yield
—
Profit Margin
-58.70%
Forward P/E
—
PEG Ratio
—
About LENSAR Inc
LENSAR, Inc., a commercial stage medical device company, is focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company is headquartered in Orlando, Florida.
Fundamentals
| Revenue (TTM) | $58.44M |
| Gross Profit (TTM) | $27.12M |
| EBITDA | $-20.08M |
| Operating Margin | -116.00% |
| Return on Equity | -1069.00% |
| Return on Assets | -22.30% |
| Revenue/Share (TTM) | $4.89 |
| Book Value | $-2.17 |
| Price-to-Book | 2.17 |
| Price-to-Sales (TTM) | 1.17 |
| EV/Revenue | 0.983 |
| EV/EBITDA | -1.04 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -4.20% |
| Shares Outstanding | $12.10M |
| Float | $8.68M |
| % Insiders | 18.83% |
| % Institutions | 48.98% |
Analyst Ratings
Consensus ($8.50 target)
1
Buy1
HoldData last updated: 4/8/2026